Filing Details

Accession Number:
0001562180-19-003055
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-22 16:12:04
Reporting Period:
2019-05-20
Accepted Time:
2019-05-22 16:12:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404281 Novus Therapeutics Inc. NVUS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705278 C. Catherine Turkel C/o Novus Therapeutics, Inc.
19900 Macarthur Blvd., Suite 550
Irvine CA 92612
President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-20 7,623 $1.96 90,576 No 4 S Direct
Common Stock Disposition 2019-05-21 1,914 $1.91 88,662 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units.
  2. This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.